Single lineage cytopenias, T-LGL

Clinical trials for Single lineage cytopenias, T-LGL explained in plain language.

Never miss a new study

Get alerted when new Single lineage cytopenias, T-LGL trials appear

Sign up with your email to follow new studies for Single lineage cytopenias, T-LGL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

New hope for rare bone marrow diseases: drug tames immune attack

Disease control Ongoing

This study tests a pill called ruxolitinib for people whose immune system attacks their bone marrow, causing conditions like severe anemia. The drug aims to stop this attack and help the bone marrow recover. Participants take the pill twice daily for up to 6 months and are follow…

Matched conditions: SINGLE LINEAGE CYTOPENIAS, T-LGL

Phase 1/2 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Disease control

Last updated Aug 20, 2026 00:00 UTC

Single lineage cytopenias, T-LGL

Get alerted when new Single lineage cytopenias, T-LGL trials appear

New hope for rare bone marrow diseases: drug tames immune attack